: Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma
Merck & Co. MRK and Moderna Inc. MRNA said Wednesday they have launched a Phase 3 trial of Moderna’s V940 in combination with Merck’s Keytruda...
: Coca-Cola’s stock up 1.9% premarket after company tops Q2 earnings estimates and raises guidance
Coca-Cola Co.’s stock KO rose 1.9% premarket Wednesday, after the drinks and snacks giant beat second-quarter earnings estimates and raised its guidance. The company had...
: Genernal Dynamics stock rises toward 3-month high after earnings beat, amid record backlog and strong cash flow
Shares of General Dynamics Corp. GD rallied 1.8% toward a three-month high in premarket trading Wednesday, after the aerospace and defense company beat second-quarter earnings...
: Cannabis company Tilray posts narrower loss as revenue climbs 20%
Tilray Brands Inc. TLRY stock was up 3% in premarket trades on Wednesday after the cannabis company reported a narrower fourth-quarter loss that missed Wall...
Kraft Heinz looks to revive Maxwell House brand with new instant iced latte with foam
Kraft Heinz's Maxwell House is launching iced lattes with foam, its first new product in nearly a decade.
Coca-Cola raises full-year outlook as earnings beat estimates
Coke has been raising prices across its portfolio, including another round of hikes during the first quarter.
Coca-Cola raises full-year outlook as earnings beat estimates
Coke has been raising prices across its portfolio, including another round of hikes during the first quarter.
AltSignals revolutionizing the trading signals industry through blockchain and AI
AltSignals is riding the AI hype with its blockchain AI-powered AI ecosystem. The project is currently conducting a presale for its native token, ASI. The...
Market Snapshot: Stock futures struggle for direction as traders await Fed comments
Divergent reactions to the earnings of Microsoft and Alphabet leave Nasdaq in line for a slightly soft start to the session